Capacity Constraints and High Valuation Cap Elbit's War-Driven Momentum

What happened

Elbit Systems posted strong 2025 results with 16% revenue growth and a 46% EPS jump, bolstered by a $28.1 billion backlog amid elevated defense spending. Yet, the stock trades at approximately 73x trailing EPS, pricing in aggressive sustained earnings growth that may be overly optimistic. Near-term revenue acceleration is limited by capacity constraints, despite the surging backlog, highlighting operational bottlenecks. Compounding this, ESG and political risks—such as UK contract losses and NATO procurement suspensions—are tangible threats that undermine market access and growth visibility. While the company is investing in European drone and ammunition production to address capacity, the current valuation leaves little room for error against these headwinds.

Implication

For investors, Elbit's robust backlog and earnings growth are offset by a valuation that demands flawless execution, yet capacity issues cap near-term revenue potential and ESG risks persist. The stock's 142% surge over 12 months reflects crowded momentum positioning, increasing vulnerability to any slowdown in order flow or margin pressure. Given the probability-weighted scenarios in the DeepValue report, which skew toward downside, new capital is better deployed elsewhere unless the price falls toward $500 for a more attractive entry. Monitoring quarterly backlog growth and ESG developments over the next 6-12 months is crucial; deterioration here would validate the POTENTIAL SELL rating. Ultimately, maintaining or reducing exposure is prudent until evidence of sustained margin expansion and resolved political overhangs emerges.

Thesis delta

The new article confirms Elbit's strong operational performance but also highlights capacity constraints that limit near-term revenue acceleration, reinforcing the DeepValue report's caution on overvaluation. No shift in the investment thesis is warranted; the POTENTIAL SELL rating remains intact as growth prospects are capped by operational bottlenecks and persistent ESG risks. Investors should await clearer signs of backlog conversion improvement or a valuation reset before reconsidering a bullish stance.